Search results
Results from the WOW.Com Content Network
Discover Oncology, formerly Hormones and Cancer, is a bimonthly peer-reviewed medical journal covering research on all aspects of hormone action on cancer. It was established in 2010 and is published by Springer Science + Business Media on behalf of The Endocrine Society. The editor-in-chief is Carol A. Lange (University of Minnesota).
JCO Global Oncology is a peer-reviewed open-access medical journal covering cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It was established in 2015 as the Journal of Global Oncology , obtaining its current name in 2020.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [4] [5] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023. [6]
In 2023, the FDA published a rule stating that mammogram reports sent to patients must include breast density, which should be described as either "not dense" or "dense." It took effect on Sept ...
Oncology: Language: English: Edited by: ... the journal has a 2023 impact factor of 14.8. [1] References ... This page was last edited on 15 October 2024, ...
The impact factor relates to a specific time period; it is possible to calculate it for any desired period. For example, the JCR also includes a five-year impact factor, which is calculated by dividing the number of citations to the journal in a given year by the number of articles published in that journal in the previous five years. [14] [15]
Radiotherapy & Oncology is a peer-reviewed medical journal in the field of radiation oncology. Commonly referred to as "The Green Journal", it is published by Elsevier on behalf of the European Society for Radiotherapy and Oncology. [1] According to the Journal Citation Reports, the journal has a 2023 impact factor of 4.9. [2]